Chronic coronary microvascular dysfunction
ICD-10 I25.85 is a billable code used to indicate a diagnosis of chronic coronary microvascular dysfunction.
Chronic coronary microvascular dysfunction (CMD) is a condition characterized by impaired function of the small coronary arteries, which can lead to myocardial ischemia despite normal coronary artery anatomy. Patients often present with symptoms such as chest pain, fatigue, and shortness of breath, which may not correlate with traditional coronary artery disease (CAD) findings. The anatomy involved includes the microvasculature of the heart, which plays a crucial role in regulating blood flow and oxygen delivery to the myocardium. Disease progression can be insidious, often leading to chronic symptoms and reduced quality of life. Diagnostic considerations include the use of non-invasive imaging techniques, such as cardiac MRI or PET scans, to assess myocardial perfusion and identify microvascular dysfunction. Additionally, coronary reactivity testing may be employed to evaluate endothelial function. CMD is often associated with risk factors such as diabetes, hypertension, and hyperlipidemia, necessitating a comprehensive approach to management and treatment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I25.85 specifically covers chronic coronary microvascular dysfunction, which may manifest as angina or ischemic symptoms without obstructive coronary artery disease. It is often associated with conditions like diabetes, hypertension, and metabolic syndrome.
I25.85 should be used when a patient presents with symptoms indicative of microvascular dysfunction, particularly when traditional coronary artery disease is ruled out. It is essential to document the specific diagnostic tests that support this diagnosis.
Documentation should include a thorough clinical history, symptom description, results from diagnostic tests such as stress tests or imaging studies, and any relevant comorbid conditions. Clear evidence of microvascular dysfunction is crucial.
